|
Volumn 55, Issue 6, 2001, Pages 357-362
|
Effect of recombinant human erythropoietin administration on lipid peroxidation and antioxidant enzyme(s) activities in preterm infants.
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ERYTHROPOIETIN;
FERRITIN;
LIPID PEROXIDE;
MALONALDEHYDE;
OXIDOREDUCTASE;
RECOMBINANT PROTEIN;
AGING;
ARTICLE;
BLOOD;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
ENZYMOLOGY;
ERYTHROCYTE;
ERYTHROCYTE TRANSFUSION;
FEMALE;
GROWTH, DEVELOPMENT AND AGING;
HUMAN;
MALE;
METABOLISM;
NEWBORN;
PREMATURITY;
RANDOMIZED CONTROLLED TRIAL;
REFERENCE VALUE;
TIME;
AGING;
ERYTHROCYTE TRANSFUSION;
ERYTHROCYTES;
ERYTHROPOIETIN;
FEMALE;
FERRITINS;
HUMANS;
INFANT, NEWBORN;
INFANT, PREMATURE;
LIPID PEROXIDES;
MALE;
MALONDIALDEHYDE;
OXIDOREDUCTASES;
RECOMBINANT PROTEINS;
REFERENCE VALUES;
TIME FACTORS;
|
EID: 0035751261
PISSN: 0386300X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (45)
|
References (0)
|